UPDATE 1-Abbott profit beats estimates on higher sales of generics

July 22 (Reuters) - Abbott Laboratories Inc reported a slightly better-than-expected quarterly profit, helped by higher sales of its branded generics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.